Preventing cancer therapeutic resistance

At AtG, we develop novel classes of drugs and biomarkers to prevent cancer therapeutic resistance

Our mission

Advance our portfolio of therapies to clinical trials and improve the lives of those affected by cancer therapeutic resistance.

Our findings

Novel mechanism of action

Innovative anti-cancer therapeutic target

Drug candidate

New small molecule candidates

New biomarker

Patient selection technology

Interested in becoming a partner?